caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...

www.todaysworkplace.org/2005/03/15/for-once-an-ada-case-that-inspires-instead-of-depresses

Mar 15, 2005 ... Emory v. AstraZeneca, recently decided by the 3rd Circuit Court of Appeals, ... which essentially penalized him for all of his accomplishments in ...

www.justice.gov/opa/pr/astrazeneca-pay-79-million-resolve-kickback-allegations

Feb 11, 2015 ... DiMattia et al. v. AstraZeneca LP et al. No. 10-910 (D. Del.). The claims settled by this agreement are allegations only; there has been no ...

jamanetwork.com/journals/jama/fullarticle/2442936

Sep 22, 2015 ... Analysis combining stages 1 (all patients) and 2 (rerandomized ... NPI Agitation/ Aggression scores for dextromethorphan-quinidine vs ... from PPD Development LP, consisting of 2 consecutive 5-week stages to ...... Tariot PN, Schneider LS, Cummings J, et al; Alzheimer's Disease Cooperative Study Group.

casetext.com/case/hood-ex-rel-mississippi-v-fresenius-med-care-holdings-inc-in-re-fresenius-granuflo-naturalyte-dialysate-prods-liab-litig

Jan 2, 2015 ... Code Ann. §§ 75–24–1 et seq. ... Through the Complaint, the Attorney General seeks injunctive relief, “disgorgement of all money wrongfully acquired by [ Fresenius] from ... Hood v. AU Optronics Corp., ––– U.S. ––––, 134 S.Ct. 736, 187 ... AstraZeneca Pharma., LP, 744 F.Supp.2d 590, 596 (N.D.Miss.2010) ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4839177

Jan 28, 2016 ... All of the reported cardiovascular outcomes during the ACCORD trial were adjudicated ..... Amylin Pharmaceutical (San Diego, CA), AstraZeneca Pharmaceuticals LP (Wilmington, .... Granger CB, Vogel V, Cummings SR, et al.

link.springer.com/article/10.1208/s12249-017-0891-1

Oct 10, 2017 ... Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling ... AstraZeneca Pharmaceuticals LP. Bevespi ... Cummings H, Schultz RD, Speck JH, Joshi V, Lechuga-Ballesteros D, Flynn B, et al.

www.resmedjournal.com/article/S0954-6111(17)30336-0/pdf

Sep 25, 2017 ... G.T. Ferguson et al. / Respiratory Medicine 134 (2018) ..... employee of Pearl Therapeutics, a division of AstraZeneca LP. Funding information.

onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-1241.2007.01336.x

Apr 10, 2007 ... SHIELD is supported by funding from AstraZeneca LP. ... hypertension and dyslipidaemia occurred across all ranges of BMI, but increased with ...